Basics Replimune Group, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $955.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.57 | 3.18% Avg Daily Range (30 D): $0.31 | 3.51% Avg Daily Range (90 D): $0.33 | 3.80% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): 5.1M Avg Daily Volume (90 D): 2.36M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 175 Avg Trade Size (Sh.) (90 D): 128 Institutional Trades Total Inst.Trades: 2,049 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $1.57M Avg Inst. Trade (90 D): $1.55M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.79M Avg Closing Trade (30 D): $2.19M Avg Closing Trade (90 D): $1.66M Avg Closing Volume: 113.8K     News Jul 23, 2025 @ 10:52 PM REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. is In... Source: Bragar Eagel & Squire, P.C. Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight May 13, 2025 @ 5:00 PM Metastatic Colorectal Cancer Clinical Trial Pipeli... Source: Delveinsight Nov 26, 2024 @ 4:55 AM Replimune Announces Pricing of Upsized Public Offe... Source: Globe Newswire Oct 23, 2024 @ 5:00 PM Non-melanoma Skin Cancer is Predicted to Exhibit R... Source: Delveinsight Financials   TTM Q4 2025 FY 2025 Basic EPS $-3.07 $-.82 $-3.07 Diluted EPS $-3.07 $-.82 $-3.07 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -247.3M $ -74.13M $ -247.3M Operating Income / Loss $ -261.63M $ -79.33M $ -261.63M Cost of Revenue $ $ $ Net Cash Flow $ 36.67M $ -61.12M $ 36.67M PE Ratio     Splits Dec 01, 2010:   15:1